Repurposing existing drugs shows promise in treating the metabolic disruption common to virtually all cancers.
In this episode of Bulletproof Radio, my guest approaches cancer much differently than mainstream medical thinking.
Dr. Charles Meakin is Chief Medical Officer for Care Oncology Clinic USA and works specifically on metabolic treatment strategies for curing cancer. He’s also a career biohacker-physician focused on alternative and holistic treatment strategies that he hopes will shape the “fourth field of cancer care.”
We talk personalized strategies and specifically about some of the drugs we take for anti-aging that are interesting for cancer care, including stuff that is a little bit shocking to me like statins. We’re going to get into that, and if you’re interested in metabolism, this show is for you.
“Cancer hits one in two men, four in 10 women, and we spend a lot of money on it,” Dr. Meakin says. “And it’s still not fixing it.”
We’re learning more every day about how cancer manifests and acts in the body. Over the last 10 years, many of the same cancer screening recommendations remain intact, but a lot has changed, such as:
Cancer is gradually catching up with cardiovascular disease as the primary cause of death in America
The emergence of obesity as the second most common risk factor for cancer
The increased prevalence of some diseases means many more will experience cancer (1/3 women, 1/2 men)
The emergence of HPV virus as a trigger for oral pharyngeal cancer is escalating
Dr. Meakin brings holistic alternatives to the normal standard of care: simple balance training programs, nutrition strategies, supplements additive, portable 02, exercise bands, sleep hacks, and more. His options not only improve treatment outcomes for patients, but helps other health conditions in an accessible, inexpensive and safe way.
“Our ultimate goal is a paradigm shift to not just let cancer develop, and then try to jump on it in our current ways once it’s done, but to work in a better way with prevention and earlier identification,” he explains.
Dr. Meakin and I explore the ways we view and treat cancer has changed over time, and how far it still has to go. You’ll learn about developments in oncology like targeted immune therapies, and a new belief called Epigenetic Theory.
He doesn’t shy away from hard questions, and that’s what makes this such a great episode.